Managing Recurrent Metastatic ER+/HER2- Breast Cancer

preview_player
Показать описание
Sara M. Tolaney, MD, MPH, discusses her impressions of a 58-year-old woman who presents with recurrent metastatic ER-positive/HER2-negative breast cancer and explains why conducting a biopsy at recurrence is critical when making decisions for how to manage the patient.

  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Managing Recurrent Metastatic 0:03:22

Managing Recurrent Metastatic ER+/HER2- Breast Cancer

Managing Recurrent Metastatic 0:06:33

Managing Recurrent Metastatic ER+ Breast Cancer

Management of HER2 0:04:01

Management of HER2 positive metastatic breast cancer treatment algorithm

Management of premenopausal 0:02:14

Management of premenopausal HR+/HER2- breast cancer with micro-metastasis

Important considerations in 0:02:05

Important considerations in the management of HR+, HER2-negative early breast cancer

Optimizing Therapy in 0:47:29

Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

Who gets Breast 0:03:27

Who gets Breast Cancer Recurrences? - with Dr Tasha

How long can 0:01:19

How long can you expect to live with metastatic breast cancer?

Breast Cancer Breakthroughs 0:14:54

Breast Cancer Breakthroughs Episode 11: Changing the Game with New Hormone Therapies

Conceptualizing Guidelines to 0:30:49

Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer

Optimizing treatment in 0:04:12

Optimizing treatment in patients with early-stage HER2-positive breast cancer

ctDNA and late 0:01:46

ctDNA and late recurrence in high-risk, HR+, HER2- breast cancer

Eribulin in Recurrent 0:04:12

Eribulin in Recurrent Metastatic ER+ Breast Cancer

The late recurrence 0:01:40

The late recurrence of ER+ breast cancer

Sequencing Treatment Options 0:02:43

Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast Conference

Expert Report on 0:06:39

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancer

Key challenge associated 0:00:35

Key challenge associated with the management of HR+/HER2- breast cancer

Optimizing Therapy in 0:49:25

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Adjuvant Therapy | 0:46:31

Adjuvant Therapy | 2023 Best of Breast Conference

How to use 0:04:22

How to use endocrine therapy in premenopausal women with ER+ metastatic breast cancer

MasterClass on Managing 0:20:19

MasterClass on Managing HER2 Positive Breast Cancer

Treatment Updated for 0:30:57

Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms

2022 KU Post 0:31:32

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy

HER2 In Breast 0:46:51

HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches